We aim to develop innovative therapies that target high unmet medical needs in oncology and bacterial infections.

We develop for patients

For 40 years we have been committed to improving patient lives. With the heritage of our successful two standard-of-care therapies for prostate & colorectal cancer, we relentlessly aspire to identify and develop innovative treatments in both oncology and bacterial infections.

Let's partner to develop your compound!

  • You are - Universities, Biotech, Big pharma

  • You are working on - Small molecules, antibodies and peptides

  • Active in - Oncology, bacterial infections

  • Your current development stage - From preclinical candidate to clinical phase I

Frédéric Lévy Executive Director, Head of Search & Evaluation and Scientific Innovation, Debiopharm International S.A.

We look for promising oncology or antibacterial compounds to transform them into valuable treatments to improve patients’ quality of life.

Connect with us

Interested in one of our programs?

  • Expertise in oncology and bacterial infections

  • Late-stage clinical development capabilities

  • Established sales force

Our clinical stage assets
Fabien Sebille Executive Director, Business Development, Debiopharm International S.A.

We have several projects ready for out-licensing and we are looking for partners.

Connect with us

Connect with us

Interested in partnering with us? Do you have an interesting product or program for oncology or antibiotics? Would you like to know more about developing or commercializing one of our products? Let's talk!

Contact form